Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma

被引:0
作者
Yue Zhao
Yakun Gao
Xiaodong Xu
Jiwu Zhou
He Wang
机构
[1] Cangzhou Central Hospital,Department II of Radiotherapy
[2] Cangzhou Central Hospital,Department of Ultrasound
[3] Cangzhou Medical College,School of Clinical Medicine
[4] Hebei Medical University,Office of Educational Administration
来源
BMC Cancer | / 21卷
关键词
Lung adenocarcinoma; Multi-omics; Prognosis; Methylation; Copy number variation; Subtype;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 206 条
[1]  
Siegel RL(2019)Cancer statistics, 2019 CA Cancer J Clin 69 7-34
[2]  
Miller KD(2019)Systematic identification of multi Omics-based biomarkers in KEAP1 mutated TCGA lung adenocarcinoma J Cancer 10 6813-6821
[3]  
Jemal A(2019)EMT-mediated acquired EGFR-TKI resistance in NSCLC: mechanisms and strategies Front Oncol 9 1044-97
[4]  
Namani A(2018)Cell death-based treatment of lung adenocarcinoma Cell Death Dis 9 117-11426
[5]  
Zheng Z(2020)Methylation in lung Cancer: a brief review Methods Mol Biol 2204 91-504.e421
[6]  
Wang XJ(2018)Role of novel histone modifications in cancer Oncotarget 9 11414-1420
[7]  
Tang X(2019)METTL13 methylation of eEF1A increases translational output to promote tumorigenesis Cell 176 491-e1081
[8]  
Zhu X(2019)JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway J Exp Clin Cancer Res 38 435-287
[9]  
Chen L(2019)Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung Cancer treated with Nivolumab JAMA Oncol 5 1411-293
[10]  
Liu L(2019)Genomic signature of driver genes identified by target next-generation sequencing in Chinese non-small cell lung Cancer Oncologist 24 e1070-2031